Hodgkin Lymphoma
Showing NaN - NaN of 11
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)
Not yet recruiting
- Hematologic Malignancy
- +10 more
- Tagraxofusp
- +8 more
-
Los Angeles, California
- +28 more
Jul 26, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Classical Hodgkin Lymphoma Trial in Atlanta (Bendamustine, Gemcitabine,
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- +3 more
- Bendamustine
- +2 more
-
Atlanta, Georgia
- +1 more
Aug 25, 2021
Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in United States (Sirolimus, Methotrexate, Tacrolimus)
Completed
- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
- Sirolimus
- +4 more
-
Atlanta, Georgia
- +4 more
Jan 30, 2019
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
- +2 more
-
Duarte, California
- +2 more
Nov 19, 2018
Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))
Completed
- Hodgkin Lymphoma
- Everolimus (RAD001)
-
Los Angeles, California
- +15 more
Apr 18, 2016